We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Hollis-Eden Pharmaceuticals (MM) | NASDAQ:HEPH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.535 | 0 | 01:00:00 |
DE
|
13-3697002
|
|
(State or other jurisdiction of
|
(IRS Employer
|
|
incorporation)
|
Identification No.)
|
Effective February 18, 2010, our common stock will begin trading under a new NASDAQ symbol, "HRBR" and CUSIP number "41150V 103". Until such time, our common stock will continue to trade under the symbol "HEPH."
Hollis-Eden Pharmaceuticals, Inc.
|
||||||||
Date: February 16, 2010
|
By:
|
/s/ /Robert Weber/
|
||||||
Robert Weber
|
||||||||
Chief Financial Officer
|
||||||||
Exhibit No.
|
Description
|
|
EX-3.1
|
Certificate of Ownership
|
1 Year Hollis-Eden Pharmaceuticals (MM) Chart |
1 Month Hollis-Eden Pharmaceuticals (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions